equity financing

7 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Adlai Nortye Raises $150M in Oversubscribed Private Placement to Fund Cancer Pipeline

$ANL raises $150M from institutional investors including Soleus Capital and Perceptive Advisors to advance RAS-targeting and cancer immunotherapy programs.
ANLinstitutional investorsprivate placement
GlobeNewswire Inc.GlobeNewswire Inc.··Na

NMG Secures $297M Equity Financing to Accelerate Graphite Mine Toward FID

Nouveau Monde Graphite raises $297M through private placement and public offering to fund Phase-2 Matawinie Mine development and advance toward final investment decision.
EPCRHYMITSYNMGcritical mineralsequity financing
BenzingaBenzinga··Lekha Gupta

PMGC Shares Surge 20% on Equity Financing Deployment Amid Year-Long Decline

PMGC Holdings ($ELAB) surged 20.89% after deploying $20M equity facility for aerospace and medical sector acquisitions, though shares remain down 98.86% year-to-date.
ELABaerospace and defenseacquisitions
BenzingaBenzinga··Namrata Sen

Paramount Skydance Secures $24B Gulf Backing for Warner Bros. Discovery Megadeal

Paramount Skydance secures $24B Gulf equity backing for Warner Bros. Discovery deal. Saudi PIF, Qatar QIA, and Abu Dhabi's L'imad hold non-voting stakes.
WBDPSKYTCEHYmergerequity financing
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Kosmos Energy Raises $185M Via Stock Offering to Reduce Debt Load

Kosmos Energy prices 97.5M share offering at $1.90/share for $185.25M gross proceeds, planning debt repayment.
KOSdebt repaymentpublic offering
BenzingaBenzinga··Blue Moon Metals Inc

Blue Moon Metals Secures C$1.3M to Advance Norwegian Copper Project

Blue Moon Metals closes C$1.3M equity raise for Norwegian copper-gold-silver project development from existing institutional investors.
BMMcritical metalscopper
BenzingaBenzinga··Prnewswire

Citius Pharma Posts Inaugural Revenue on LYMPHIR™ Commercial Launch

Citius Pharma reports first revenue of $3.9M from LYMPHIR™ launch, raises $20.9M to support growth and advance pipeline candidates.
CTXRCTORorphan drugimmunotherapy